Search Results
The potential of CS1-targeted CAR-T therapy in multiple myeloma
Incorporating BCMA-targeted CAR-T therapy in the frontline treatment of multiple myeloma
The value of CAR-T cell therapy for the treatment of R/R multiple myeloma
Optimizing CAR-T therapy for patients with multiple myeloma in the real-world
What You Need to Know About CAR T-Cell Therapy in Multiple Myeloma: A Deep Dive
What Other Targets are Being Explored in CAR-T Cell Therapy? #myeloma
What are the main improvements in next-generation CAR T-cell products?
Targeting CAFs in the bone marrow to prevent CAR-T resistance in multiple myeloma
How BCMA targeting bispecific antibodies may impact the subsequent use of CAR-T therapy in myeloma
Role of CAR T Therapy in Treatment Strategies - Ravi Vij, MD | MCRT Webcast October 31 (8/10)
What are myeloma targets? #myeloma
Is CAR-T Cell Therapy the Answer or an Option? - Nina Shah, MD | MCRT Miami, Florida May 21, 2022
